Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06509984 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Study acronym: EBULO
StatusRecruiting
PhasePhase 2
Started2024-08-06
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 24, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2025-02-21
Study Identification, Study Status, Oversight, Contacts/Locations v4
Primary completion date2025-06-01→2025-10-01
Completion date2025-12-01→2026-04-01
Start dateestimated 2024-11-01→confirmed 2024-08-06
Study sitesdetails revised at 3 of 4 sites
Study titlerevised
A 20-Week Study Assessing the Efficacy of Apremilast in Patients Withwith EB Simplex Generalized
2024-11-04
Study Status, Conditions v3
Re-verified, no change to tracked fields
2024-10-18
Not Yet Recruiting→Recruiting Study Status, Conditions, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-08-01→2025-06-01
Completion date2025-08-01→2025-12-01
Study sitesdetails revised at 4 of 4 sites
2024-10-17
Study Identification, Study Status v1
Primary completion date2024-08-01→2025-08-01
Completion date2024-08-01→2025-08-01
Start date2024-08-01→2024-11-01
Study title-46 characters
A 20-Week Multicentre, Open Study Assessing the Efficacy and Safety of Apremilast in Patients > 6 Years of Age With EB Simplex Generalized
2024-07-18
Original filing
The goal of this clinical trial is to Assessing the Efficacy and Safety of Apremilast in Patients \> 6 years of age with EB simplex generalized . The main question it aims to answer are: describe efficacity of this treatment. Participants will take treatments and have to use bullets during the study period.
Trial Details
NCT Number NCT06509984
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Epidermolysis Bullosa Simplex, Genodermatosis
Enrollment 20 participants
Start Date 2024-08-06
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-24